Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Blocking interferon-gamma might help treat various autoimmune diseases.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Alopecia areata can be an early sign of Hodgkin’s lymphoma and may improve with lymphoma treatment.

Low oxygen conditions improve how well certain stem cells from embryos can make hair grow longer and faster.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

The document concludes that Borrelia afzelii causes a skin condition in France, a gene is linked to hair loss in Caucasian women, and various genetic mutations affect skin diseases.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Hair follicles could help develop eye treatments by studying immune responses.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

New treatments for hair loss show promise, including plasma, stem cells, and hair-stimulating complexes, but more research is needed to fully understand them.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Skin issues can indicate immune system problems.

MILL molecules are unique immune proteins in mice that don't need TAP to appear on cell surfaces.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Vitamin D receptor is crucial for skin wound healing.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Early treatment with immunoglobulin and aspirin reduces heart complications in children with Kawasaki disease.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Modified rat stem cells on a special scaffold improved blood vessel formation and wound healing in skin substitutes.